株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

再生医療・細胞療法の将来 2025年

The Future of Tissue Engineering and Cell Therapy to 2025

発行 Smithers Apex 商品コード 328501
出版日 ページ情報 英文 376 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
再生医療・細胞療法の将来 2025年 The Future of Tissue Engineering and Cell Therapy to 2025
出版日: 2015年05月01日 ページ情報: 英文 376 Pages
概要

2014年における世界の再生医療・細胞療法市場は、約99億米ドルに達したと推計されています。同市場は今後21%のCAGRで推移し、2025年までに730億に拡大すると予測されています。

当レポートでは、世界の再生医療・細胞療法市場について調査し、臨床領域別の分析、規制状況、および主要企業のプロファイルなどをまとめ、お届けいたします。

エグゼクティブサマリー

イントロダクション・調査範囲・調査手法・定義

背景

  • 概要
  • 再生医療を支える技術
  • 細胞療法研究・技術

臨床的障害・治療ニーズ

  • がん治療ニーズの概要
  • 自己免疫疾患
  • 整形外科
  • 泌尿器科
  • 皮膚、外皮系
  • 歯科
  • 臓器移植・修復
  • 眼科
  • 一般、胃腸科、婦人科およびその他

再生医療・細胞療法の開発:臨床領域別

  • ほとんど、もしくは全ての臨床領域で用いられる開発
  • がん
  • 心血管・血管
  • 整形外科
  • 泌尿器科
  • 歯周病
  • 臓器移植・修復
  • 眼科
  • 一般、胃腸科、婦人科およびその他
  • 主要組織の概要
  • 再生医療・細胞療法の治験

世界の規制・医療費償還情勢

  • 規制
  • 医療費償還
  • 知的財産・主な特許

再生医療・細胞療法産業の概要

  • 競合の度合い
  • M&A活動
  • 市場ダイナミクス
  • 成長促進因子・阻害因子
  • 投資レベル
  • 再生医療・細胞療法における機会

世界の再生医療・細胞療法市場

  • 世界の再生医療・細胞療法市場
  • 世界のがん関連再生医療・細胞療法市場
  • 世界のがん再生医療・細胞療法市場
  • 世界の心血管・血管再生医療・細胞療法市場
  • 世界の自己免疫再生医療・細胞療法市場
  • 世界の整形外科再生医療・細胞療法市場
  • 世界の泌尿器科再生医療・細胞療法市場
  • 世界の皮膚/外皮再生医療・細胞療法市場
  • 世界の歯科再生医療・細胞療法市場
  • 世界の臓器移植・修復再生医療・細胞療法市場
  • 世界の眼科再生医療・細胞療法市場
  • 世界の一般、胃腸科、婦人科およびその他再生医療・細胞療法市場

企業プロファイル

図表リスト

目次

What does the report cover?

The global tissue engineering and cell therapy market stood at nearly $9.9 billion in 2014 and is forecast to see an annual average growth rate of 21% to reach a value of around $73 billion by 2025. Tissue engineering, once considered a sub-field of biomaterials, has grown in scope and importance and is now considered a field in its own right. This report covers engineered or regenerated biological tissues and the products used to create them which are then applied to the treatment of disease and trauma types. The report also covers cell therapy, including the use of stem cells also used to treat disease and trauma. ‘The Future of Tissue Engineering and Cell Therapy to 2025’ provides detailed analysis of these applications which cover virtually all areas of medicine including cardiology, neurology, gastroenterology, gynaecology and various forms of cancer.

Got an individual business requirement?

If you are looking to grow your business, launch new products or find out about new and emerging markets, Smithers Apex Consultancy can provide you with bespoke, practical and cost effective research solutions to meet your specific business needs.

We can deliver:

  • Unique global market focus
  • Consultancy expertise in market sizing, forecasting, strategic business planning and due diligence
  • A team of industry experts, leading consultants and researchers in over 50 countries
  • Strong relationships with key business decision makers

What will you discover?

  • A detailed overview of the technical and clinical characteristics of the key tissue engineering and cell therapy methods and products
  • In-depth analysis of the market dynamics as well as the current and anticipated development pattern for the tissue engineering and cell therapy industry
  • Quantitative market sizing including geographical breakdown to 2025 to drive your business towards growth

Table of Contents

Executive summary

Objectives, scope, methodology and definitions

  • Objectives
  • Scope of this report
  • Methodology
  • Definitions

Background

  • Overview
  • Tissue engineering supportive technologies
    • Biomaterials scaffolds
    • Nanotechnology
    • 3-dimensional bio printing
    • Microfluidics
    • Bioreactors
    • Cryopreservation and storage technologies
  • Cell therapy research and technology
    • Overview of cell therapy
    • Overview of stem cells
    • Towards the use of cell therapy
    • Cell therapy production
    • Recent developments in cell therapy production
    • The International Cell
    • Therapy Banking Initiative Project

Clinical disorders and treatment needs

  • Overview of cancer treatment needs
    • Melanoma
    • Pancreatic cancer
    • Haematopoiesis
    • Cardiovascular and vascular
    • Congestive heart failure
    • Heart attack
    • Dysfunctional heart valves
    • Peripheral vascular disorders
      • Abdominal aortic aneurysm
      • Brain aneurysm
    • Ischemic stroke
  • Autoimmune diseases
    • Graft versus host disease (GvHD)
  • Orthopaedics
    • Non-union fractures
    • Cartilage and connective tissue damage and repair
    • Ligament damage
    • Vertebral disc damage
    • Osteoarthritis
  • Urological
    • Corporal bodies
    • Urethra
    • Bladder
  • Skin, integumentary system
    • Wound healing
    • Hair
  • Dental
    • Missing teeth
    • Gum disease
  • Organ replacement and repair
    • Pancreas
      • Diabetes mellitus
    • Lung
    • Liver
    • Kidney
  • Ophthalmology
    • Cornea
    • Retina
  • General, gastrointestinal, gynaecological and other
    • Crohn's disease
    • Nerve and neurological conditions
    • Ear repair or replacement
    • Nose repair or replacement
    • Esophagus
    • Trachea
    • Stomach
    • Small intestine
    • Large intestine
    • Bladder
    • Uterus
    • Cervix
    • Penis
    • Other

Tissue engineering and cell therapy developments by clinical area

  • Developments with applications in most or all clinical areas
    • Biodegradable scaffold design for delivery of cells, factors
    • 4-D tissue engineering
  • Cancer
  • Cardiovascular and vascular
  • Orthopaedics
  • Urology
  • Periodontics
  • Organ replacement and repair
  • Ophthalmology
  • General, gastrointestinal, gynaecological and other
  • Overview of key tissue
  • Engineering and cell therapy clinical trials

Global regulatory and reimbursement landscape

  • Regulatory
  • Reimbursement
  • Intellectual property and key patents
    • Stem cell patents
      • The patentability of stem cell lines
      • Individual country policies
    • Tissue engineering and cell therapy patents

Tissue engineering and cell therapy industry overview

  • Intensity of competition
  • Merger and acquisition activity
  • Market dynamics
  • Growth drivers and restraints
  • Investment levels
  • Opportunities in tissue engineering and cell therapy

Global markets for tissue engineering and cell therapy

  • Global market for tissue engineering and cell therapy
    • US market for tissue engineering and cell therapy
    • European Union market for tissue engineering and cell therapy
    • Japan market for tissue engineering and cell therapy
    • Rest of World market for tissue engineering and cell therapy
  • Global market for cancer related tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global market for cancer tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global market for cardiovascular and vascular tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for autoimmune tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for orthopaedic tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for urological tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for skin/integumentary tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for dental tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for organ replacement and repair tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for ophthalmology tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for general, gastrointestinal, gynaecological and other tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World

Company profiles

Tables and figures

  • Summary markets, 2014-2025
  • Summary market shares, 2014
  • Incidence of
    • Congestive heart failure
    • Myocardial infarction
    • Dysfunctional heart valves
  • Incidence & prevalence of
    • Melanoma
    • Pancreatic cancer
    • Leukaemia
    • Peripheral vascular disorders
    • Abdominal aortic aneurysm
    • Brain aneurysm
    • Ischemic stroke
    • Graft vs. host disease
    • Non-union fractures incidence
    • Cartilage and connective
    • tissue damage
    • Vertebral disc damage
    • Osteoarthritis
    • Difficult-to-heal wounds
    • Baldness
    • Periodontal diseases
    • Diabetes mellitus
    • Lung disease
    • Liver disease
    • Kidney disease
    • Corneal disease
    • Retinitis pigmentosa
    • Age-related macular degeneration
    • Crohn's disease
    • Amyotrophic lateral sclerosis
    • Parkinson's disease
    • Epilepsy
    • Spinal cord injury
    • Multiple sclerosis
  • Product/technology innovations applicable to broad clinical areas
  • Product/technology innovations with
    • Cancer treatment applications
    • Cardiovascular and vascular treatment applications
    • Orthopaedic treatment applications
    • Urological treatment applications
    • Periodontal applications
    • Applications in organ replacement and repair
    • Applications in ophthalmology
  • Product/technology innovations applicable to general, gastrointestinal, gynaecological and other treatments
  • Key elements of regulatory requirements of cell-based tissue engineering and cell therapy by country
  • Key elements of reimbursement for cell-based tissue engineering and cell therapy by country
  • Key tissue engineering and cell therapy patents
  • Drivers & restraints in tissue engineering and cell therapy
  • Global market for tissue engineering and cell therapy, 2014-2025
  • Market for tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for cancer-related tissue engineering and cell therapy, 2014-2025
  • Market for cancer-related tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for cardiovascular & vascular related tissue engineering and cell therapy, 2014-2025
  • Market for cardiovascular & vascular related tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for autoimmune tissue engineering and cell therapy, 2014-2025
  • Market for autoimmune tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for orthopaedic tissue engineering and cell therapy, 2014-2025
  • Market for orthopaedic tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for neurological tissue engineering and cell therapy, 2014-2025
  • Market for neurological tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Market for urological tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for skin/integumentary tissue engineering and cell therapy, 2014-2025
  • Market for skin/integumentary tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for dental tissue engineering and cell therapy, 2014-2025
  • Market for dental tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for organ replacement & repair tissue engineering and cell therapy, 2014-2025
  • Market for organ replacement & repair tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for ophthalmological tissue engineering and cell therapy, 2014-2025
  • Market for ophthalmological tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for general, GI, GYN & other tissue engineering and cell therapy, 2014-2025
  • Market for general, GI, GYN & other tissue engineering and cell therapy, 2014-2025
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
Back to Top